Stay updated on Dapirolizumab Pegol Safety in Lupus Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.

Latest updates to the Dapirolizumab Pegol Safety in Lupus Clinical Trial page
- CheckyesterdayChange DetectedTwo new history lines dated 2026-08-21 introduce Contacts/Locations and Study Status updates, accompanied by a 2026-08-20 entry (102); a 2026-08-07 entry was removed.SummaryDifference0.2%

- Check8 days agoChange DetectedA new version entry (v3.6.5) is added to the record history. It introduces Contacts/Locations and Study Status sections to the page, signaling updated management information and current status visibility.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedA new history entry on 2026-07-24 (revision v3.6.4) adds Contacts/Locations and Study Status sections to the record, while the 2026-07-10 entry (revision v3.6.3) is removed from the history.SummaryDifference0.2%

- Check44 days agoChange DetectedA new version entry appears in the study history on 2026-07-10, introducing updated Study Status and Contacts/Locations. The prior 2026-06-26 entry was removed.SummaryDifference0.2%

- Check51 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3 at the bottom of the page, reflecting a new site release. This update does not affect study data, records, or navigation on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedThe history shows a new 2026-06-26 entry adding Contacts/Locations and Study Status with Revision: v3.6.2, updating the record from the previous v3.6.0 entry.SummaryDifference0.2%

Stay in the know with updates to Dapirolizumab Pegol Safety in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.